Loading viewer...
earnings
Format: PDF earnings
Novartis presents Q2 2024 financial results and company overview as of July 18, 2024. The presentation covers financial review, strategic initiatives including the MorphoSys acquisition, and Novartis's transformation into a pure-play innovative medicines company following the Sandoz spin-off.
brochure
earnings
15 Pages
Wipro Limited
U.S. Steel Q2 2023 Earnings Call
earningsearnings
36 Pages
United States Steel Corporation